Wei Heng

ORCID: 0009-0007-2772-0146
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • interferon and immune responses
  • Magnesium in Health and Disease
  • Immunotherapy and Immune Responses
  • Protease and Inhibitor Mechanisms
  • Chemical Synthesis and Analysis
  • Phagocytosis and Immune Regulation
  • Lipoproteins and Cardiovascular Health
  • Nuclear Receptors and Signaling
  • Cytokine Signaling Pathways and Interactions
  • Chemokine receptors and signaling
  • Kruppel-like factors research
  • Endoplasmic Reticulum Stress and Disease
  • Biopolymer Synthesis and Applications
  • Cancer-related gene regulation
  • Medical Research and Treatments
  • Parathyroid Disorders and Treatments
  • Thyroid and Parathyroid Surgery
  • Galectins and Cancer Biology
  • Fibroblast Growth Factor Research
  • Eicosanoids and Hypertension Pharmacology
  • Atherosclerosis and Cardiovascular Diseases
  • RNA Interference and Gene Delivery

Background Although favorable outcomes have been reported with radiofrequency ablation (RFA) for secondary hyperparathyroidism (SHPT), the long-term efficacy remains insufficiently investigated. Purpose To evaluate and safety of US-guided percutaneous RFA in patients SHPT undergoing dialysis to identify possible predictors associated treatment failure. Materials Methods This retrospective study included consecutive at least one enlarged parathyroid gland accessible who were seven tertiary...

10.1148/radiol.231852 article EN Radiology 2024-04-01

目的 探讨高血压人群氧化应激状况,以期为临床高血压病人抗氧化治疗提供理论研究基础.结果在高血压人群中,总抗氧化能力(T-AOC)低于非高血压人群,而MDA含量高于非高血压人群,且差异具有显著性,而作为主要抗氧化因素的SOD和VitE水平差异无显著性.结论高血压病人处于高氧化应激水平,临床应用抗氧化药物治疗高血压可能有一定疗效。

10.3760/cma.j.issn.1008-634x.2006.01.005 article KO Xiandai linchuang yixue shengwu gongchengxue zazhi 2006-02-28
Coming Soon ...